rs2230307

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBA1

The NM_000642.3(AGL):​c.3343G>A​(p.Gly1115Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0576 in 1,613,468 control chromosomes in the GnomAD database, including 3,757 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G1115G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.056 ( 344 hom., cov: 32)
Exomes 𝑓: 0.058 ( 3413 hom. )

Consequence

AGL
NM_000642.3 missense

Scores

7
7
4

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 9.58
Variant links:
Genes affected
AGL (HGNC:321): (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 6: Cadd, Dann, Eigen, MutationAssessor, phyloP100way_vertebrate, PROVEAN [when BayesDel_addAF, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP6
Variant 1-99896369-G-A is Benign according to our data. Variant chr1-99896369-G-A is described in ClinVar as [Benign]. Clinvar id is 256738.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-99896369-G-A is described in Lovd as [Pathogenic].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.153 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGLNM_000642.3 linkc.3343G>A p.Gly1115Arg missense_variant Exon 25 of 34 ENST00000361915.8 NP_000633.2 P35573-1A0A0S2A4E4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGLENST00000361915.8 linkc.3343G>A p.Gly1115Arg missense_variant Exon 25 of 34 1 NM_000642.3 ENSP00000355106.3 P35573-1

Frequencies

GnomAD3 genomes
AF:
0.0562
AC:
8550
AN:
152086
Hom.:
342
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0288
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.121
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.162
Gnomad SAS
AF:
0.0496
Gnomad FIN
AF:
0.0728
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0508
Gnomad OTH
AF:
0.0612
GnomAD3 exomes
AF:
0.0735
AC:
18478
AN:
251422
Hom.:
1141
AF XY:
0.0672
AC XY:
9127
AN XY:
135874
show subpopulations
Gnomad AFR exome
AF:
0.0283
Gnomad AMR exome
AF:
0.177
Gnomad ASJ exome
AF:
0.0110
Gnomad EAS exome
AF:
0.158
Gnomad SAS exome
AF:
0.0480
Gnomad FIN exome
AF:
0.0699
Gnomad NFE exome
AF:
0.0489
Gnomad OTH exome
AF:
0.0572
GnomAD4 exome
AF:
0.0577
AC:
84341
AN:
1461264
Hom.:
3413
Cov.:
31
AF XY:
0.0566
AC XY:
41177
AN XY:
727008
show subpopulations
Gnomad4 AFR exome
AF:
0.0278
Gnomad4 AMR exome
AF:
0.171
Gnomad4 ASJ exome
AF:
0.0125
Gnomad4 EAS exome
AF:
0.185
Gnomad4 SAS exome
AF:
0.0479
Gnomad4 FIN exome
AF:
0.0700
Gnomad4 NFE exome
AF:
0.0510
Gnomad4 OTH exome
AF:
0.0559
GnomAD4 genome
AF:
0.0562
AC:
8556
AN:
152204
Hom.:
344
Cov.:
32
AF XY:
0.0586
AC XY:
4361
AN XY:
74426
show subpopulations
Gnomad4 AFR
AF:
0.0287
Gnomad4 AMR
AF:
0.121
Gnomad4 ASJ
AF:
0.0107
Gnomad4 EAS
AF:
0.162
Gnomad4 SAS
AF:
0.0492
Gnomad4 FIN
AF:
0.0728
Gnomad4 NFE
AF:
0.0508
Gnomad4 OTH
AF:
0.0597
Alfa
AF:
0.0507
Hom.:
449
Bravo
AF:
0.0599
TwinsUK
AF:
0.0564
AC:
209
ALSPAC
AF:
0.0446
AC:
172
ESP6500AA
AF:
0.0261
AC:
115
ESP6500EA
AF:
0.0498
AC:
428
ExAC
AF:
0.0688
AC:
8357
Asia WGS
AF:
0.111
AC:
384
AN:
3478
EpiCase
AF:
0.0436
EpiControl
AF:
0.0412

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease type III Benign:4
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 29, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Oct 26, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Uncertain
-0.030
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.37
T;T;T;T;.
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.98
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;.;.;.;D
MetaRNN
Benign
0.0033
T;T;T;T;T
MetaSVM
Uncertain
0.37
D
MutationAssessor
Pathogenic
3.1
M;M;M;M;.
PrimateAI
Uncertain
0.73
T
PROVEAN
Pathogenic
-7.4
D;D;D;D;D
REVEL
Uncertain
0.57
Sift
Uncertain
0.0030
D;D;D;D;D
Sift4G
Uncertain
0.040
D;D;D;D;D
Polyphen
1.0
D;D;D;D;D
Vest4
0.45
MutPred
0.59
Gain of MoRF binding (P = 0.0134);Gain of MoRF binding (P = 0.0134);Gain of MoRF binding (P = 0.0134);Gain of MoRF binding (P = 0.0134);.;
MPC
0.31
ClinPred
0.057
T
GERP RS
5.9
Varity_R
0.83
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.36
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.36
Position offset: 19

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2230307; hg19: chr1-100361925; COSMIC: COSV54048879; API